147 related articles for article (PubMed ID: 29482947)
1. Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.
Jabir FA; Hoidy WH
Clin Breast Cancer; 2018 Oct; 18(5):e863-e868. PubMed ID: 29482947
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
Cocca M; Bedognetti D; La Bianca M; Gasparini P; Girotto G
J Transl Med; 2016 Jan; 14():22. PubMed ID: 26801900
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Genetic Polymorphisms in the
Luo Y; Luo J; Peng H
Genet Test Mol Biomarkers; 2019 Sep; 23(9):644-651. PubMed ID: 31524543
[No Abstract] [Full Text] [Related]
4. E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.
Xia HZ; Du WD; Wu Q; Chen G; Zhou Y; Tang XF; Tang HY; Liu Y; Yang F; Ruan J; Xu S; Zuo XB; Zhang XJ
Mol Carcinog; 2012 Aug; 51(8):597-607. PubMed ID: 21780194
[TBL] [Abstract][Full Text] [Related]
5. Superoxide Dismutase (rs2070424, rs4880, rs2536512) and Catalase (rs794316, rs1001179) SNPs and their Association with Breast Cancer Risk: Findings from a Hospital Based Case-Control Study.
Datkhile KD; Gudur RA; Bhosale SJ; Gudur AK; Durgawale PP; Jagdale NJ; More AL; Patil SR
Asian Pac J Cancer Prev; 2024 Jan; 25(1):175-184. PubMed ID: 38285782
[TBL] [Abstract][Full Text] [Related]
6. A Case-Control Study on Association of Ulcerative Colitis with FCGR2A Gene Polymorphisms in Chinese Patients.
Xia SL; Lin DP; Lin QR; Sun L; Wang XQ; Hong WJ; Lin ZJ; Du CC; Jiang Y
Genet Test Mol Biomarkers; 2018 Oct; 22(10):607-614. PubMed ID: 30260678
[TBL] [Abstract][Full Text] [Related]
7. Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis.
Zhang C; Wang W; Zhang H; Wei L; Guo S
Oncotarget; 2016 Jun; 7(26):39436-39443. PubMed ID: 27270653
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of single nucleotide polymorphisms and haplotypes of FCGR2A gene among patients with ulcerative colitis].
Zhang D; Min X; Wang J; Jiang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):811-815. PubMed ID: 27984611
[TBL] [Abstract][Full Text] [Related]
9. A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.
Duan J; Lou J; Zhang Q; Ke J; Qi Y; Shen N; Zhu B; Zhong R; Wang Z; Liu L; Wu J; Wang W; Gong F; Miao X
PLoS One; 2014; 9(8):e103329. PubMed ID: 25093412
[TBL] [Abstract][Full Text] [Related]
10. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
11. The effect of GPx-1 rs1050450 and MnSOD rs4880 polymorphisms on PE susceptibility: a case- control study.
Teimoori B; Moradi-Shahrebabak M; Razavi M; Rezaei M; Harati-Sadegh M; Salimi S
Mol Biol Rep; 2019 Dec; 46(6):6099-6104. PubMed ID: 31512047
[TBL] [Abstract][Full Text] [Related]
12. Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility.
Shi X; Ma Y; Li H; Yu H
BMC Med Genet; 2020 Apr; 21(1):71. PubMed ID: 32252656
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
14. CYP2C19 Genotype is an Independent Predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel After Percutaneous Coronary Intervention.
Mohammad AM; Al-Allawi NAS
J Cardiovasc Pharmacol; 2018 Jun; 71(6):347-351. PubMed ID: 29554005
[TBL] [Abstract][Full Text] [Related]
15. [Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease].
Ji YX; Zhang HY; Lin SX
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):196-200. PubMed ID: 23498761
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
Helsby N; Yong M; Burns K; Findlay M; Porter D
Cancer Chemother Pharmacol; 2021 Sep; 88(3):533-542. PubMed ID: 34114066
[TBL] [Abstract][Full Text] [Related]
17. Plasma antioxidant concentration, not superoxide dismutase polymorphism, is associated with breast cancer risk in Korean women.
Kim MK; Ahn SH; Son BH; Sung MK
Nutr Res; 2010 Oct; 30(10):705-13. PubMed ID: 21056286
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of FCGR2A, ORAI1 and CD40 are associated with risk of lung cancer.
He J; Yu L; Qiao Z; Yu B; Liu Y; Ren H
Eur J Cancer Prev; 2022 Jan; 31(1):7-13. PubMed ID: 34871197
[TBL] [Abstract][Full Text] [Related]
19. Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
Lim JS; Sutiman N; Muerdter TE; Singh O; Cheung YB; Ng RC; Yap YS; Wong NS; Ang PC; Dent R; Schroth W; Schwab M; Chowbay B
Br J Clin Pharmacol; 2016 Jun; 81(6):1142-52. PubMed ID: 26799162
[TBL] [Abstract][Full Text] [Related]
20. The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients.
Gudur RA; Bhosale SJ; Gudur AK; Kale SR; More AL; Datkhile KD
Asian Pac J Cancer Prev; 2024 Jun; 25(6):1977-1986. PubMed ID: 38918659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
